Understanding household-level risk factors for zero dose immunization in 82 low- and middle-income countries.

<h4>Introduction</h4>In 2021, an estimated 18 million children did not receive a single dose of routine vaccinations and constitute the population known as zero dose children. There is growing momentum and investment in reaching zero dose children and addressing the gross inequity in the...

Full description

Saved in:
Bibliographic Details
Main Authors: Brooke Amara Farrenkopf, Xiaobin Zhou, Anita Shet, Folake Olayinka, Kelly Carr, Bryan Patenaude, Onyema Greg Chido-Amajuoyi, Chizoba Wonodi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0287459&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850184455335968768
author Brooke Amara Farrenkopf
Xiaobin Zhou
Anita Shet
Folake Olayinka
Kelly Carr
Bryan Patenaude
Onyema Greg Chido-Amajuoyi
Chizoba Wonodi
author_facet Brooke Amara Farrenkopf
Xiaobin Zhou
Anita Shet
Folake Olayinka
Kelly Carr
Bryan Patenaude
Onyema Greg Chido-Amajuoyi
Chizoba Wonodi
author_sort Brooke Amara Farrenkopf
collection DOAJ
description <h4>Introduction</h4>In 2021, an estimated 18 million children did not receive a single dose of routine vaccinations and constitute the population known as zero dose children. There is growing momentum and investment in reaching zero dose children and addressing the gross inequity in the reach of immunization services. To effectively do so, there is an urgent need to characterize more deeply the population of zero dose children and the barriers they face in accessing routine immunization services.<h4>Methods</h4>We utilized the most recent DHS and MICS data spanning 2011 to 2020 from low, lower-middle, and upper-middle income countries. Zero dose status was defined as children aged 12-23 months who had not received any doses of BCG, DTP-containing, polio, and measles-containing vaccines. We estimated the prevalence of zero-dose children in the entire study sample, by country income level, and by region, and characterized the zero dose population by household-level factors. Multivariate logistic regressions were used to determine the household-level sociodemographic and health care access factors associated with zero dose immunization status. To pool multicountry data, we adjusted the original survey weights according to the country's population of children 12-23 months of age. To contextualize our findings, we utilized United Nations Population Division birth cohort data to estimate the study population as a proportion of the global and country income group populations.<h4>Results</h4>We included a total of 82 countries in our univariate analyses and 68 countries in our multivariate model. Overall, 7.5% of the study population were zero dose children. More than half (51.9%) of this population was concentrated in African countries. Zero dose children were predominantly situated in rural areas (75.8%) and in households in the lowest two wealth quintiles (62.7%) and were born to mothers who completed fewer than four antenatal care (ANC) visits (66.5%) and had home births (58.5%). Yet, surprisingly, a considerable proportion of zero dose children's mothers did receive appropriate care during pregnancy (33.5% of zero dose children have mothers who received at least 4 ANC visits). When controlled for other factors, children had three times the odds (OR = 3.00, 95% CI: 2.72, 3.30) of being zero dose if their mother had not received any tetanus injections, 2.46 times the odds (95% CI: 2.21, 2.74) of being zero dose if their mother had not received any ANC visits, and had nearly twice the odds (OR = 1.87, 95% CI: 1.70, 2.05) of being zero dose if their mother had a home delivery, compared to children of mothers who received at least 2 tetanus injections, received at least 4 ANC visits, and had a facility delivery, respectively.<h4>Discussion</h4>A lack of access to maternal health care was a strong risk factor of zero dose status and highlights important opportunities to improve the quality and integration of maternal and child health programs. Additionally, because a substantial proportion of zero dose children and their mothers do receive appropriate care, approaches to reach zero dose children should incorporate mitigating missed opportunities for vaccination.
format Article
id doaj-art-0bcdf6c3fc27443abecde99ed3b75992
institution OA Journals
issn 1932-6203
language English
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-0bcdf6c3fc27443abecde99ed3b759922025-08-20T02:17:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-011812e028745910.1371/journal.pone.0287459Understanding household-level risk factors for zero dose immunization in 82 low- and middle-income countries.Brooke Amara FarrenkopfXiaobin ZhouAnita ShetFolake OlayinkaKelly CarrBryan PatenaudeOnyema Greg Chido-AmajuoyiChizoba Wonodi<h4>Introduction</h4>In 2021, an estimated 18 million children did not receive a single dose of routine vaccinations and constitute the population known as zero dose children. There is growing momentum and investment in reaching zero dose children and addressing the gross inequity in the reach of immunization services. To effectively do so, there is an urgent need to characterize more deeply the population of zero dose children and the barriers they face in accessing routine immunization services.<h4>Methods</h4>We utilized the most recent DHS and MICS data spanning 2011 to 2020 from low, lower-middle, and upper-middle income countries. Zero dose status was defined as children aged 12-23 months who had not received any doses of BCG, DTP-containing, polio, and measles-containing vaccines. We estimated the prevalence of zero-dose children in the entire study sample, by country income level, and by region, and characterized the zero dose population by household-level factors. Multivariate logistic regressions were used to determine the household-level sociodemographic and health care access factors associated with zero dose immunization status. To pool multicountry data, we adjusted the original survey weights according to the country's population of children 12-23 months of age. To contextualize our findings, we utilized United Nations Population Division birth cohort data to estimate the study population as a proportion of the global and country income group populations.<h4>Results</h4>We included a total of 82 countries in our univariate analyses and 68 countries in our multivariate model. Overall, 7.5% of the study population were zero dose children. More than half (51.9%) of this population was concentrated in African countries. Zero dose children were predominantly situated in rural areas (75.8%) and in households in the lowest two wealth quintiles (62.7%) and were born to mothers who completed fewer than four antenatal care (ANC) visits (66.5%) and had home births (58.5%). Yet, surprisingly, a considerable proportion of zero dose children's mothers did receive appropriate care during pregnancy (33.5% of zero dose children have mothers who received at least 4 ANC visits). When controlled for other factors, children had three times the odds (OR = 3.00, 95% CI: 2.72, 3.30) of being zero dose if their mother had not received any tetanus injections, 2.46 times the odds (95% CI: 2.21, 2.74) of being zero dose if their mother had not received any ANC visits, and had nearly twice the odds (OR = 1.87, 95% CI: 1.70, 2.05) of being zero dose if their mother had a home delivery, compared to children of mothers who received at least 2 tetanus injections, received at least 4 ANC visits, and had a facility delivery, respectively.<h4>Discussion</h4>A lack of access to maternal health care was a strong risk factor of zero dose status and highlights important opportunities to improve the quality and integration of maternal and child health programs. Additionally, because a substantial proportion of zero dose children and their mothers do receive appropriate care, approaches to reach zero dose children should incorporate mitigating missed opportunities for vaccination.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0287459&type=printable
spellingShingle Brooke Amara Farrenkopf
Xiaobin Zhou
Anita Shet
Folake Olayinka
Kelly Carr
Bryan Patenaude
Onyema Greg Chido-Amajuoyi
Chizoba Wonodi
Understanding household-level risk factors for zero dose immunization in 82 low- and middle-income countries.
PLoS ONE
title Understanding household-level risk factors for zero dose immunization in 82 low- and middle-income countries.
title_full Understanding household-level risk factors for zero dose immunization in 82 low- and middle-income countries.
title_fullStr Understanding household-level risk factors for zero dose immunization in 82 low- and middle-income countries.
title_full_unstemmed Understanding household-level risk factors for zero dose immunization in 82 low- and middle-income countries.
title_short Understanding household-level risk factors for zero dose immunization in 82 low- and middle-income countries.
title_sort understanding household level risk factors for zero dose immunization in 82 low and middle income countries
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0287459&type=printable
work_keys_str_mv AT brookeamarafarrenkopf understandinghouseholdlevelriskfactorsforzerodoseimmunizationin82lowandmiddleincomecountries
AT xiaobinzhou understandinghouseholdlevelriskfactorsforzerodoseimmunizationin82lowandmiddleincomecountries
AT anitashet understandinghouseholdlevelriskfactorsforzerodoseimmunizationin82lowandmiddleincomecountries
AT folakeolayinka understandinghouseholdlevelriskfactorsforzerodoseimmunizationin82lowandmiddleincomecountries
AT kellycarr understandinghouseholdlevelriskfactorsforzerodoseimmunizationin82lowandmiddleincomecountries
AT bryanpatenaude understandinghouseholdlevelriskfactorsforzerodoseimmunizationin82lowandmiddleincomecountries
AT onyemagregchidoamajuoyi understandinghouseholdlevelriskfactorsforzerodoseimmunizationin82lowandmiddleincomecountries
AT chizobawonodi understandinghouseholdlevelriskfactorsforzerodoseimmunizationin82lowandmiddleincomecountries